HCPCS 2018

A9543 Yttrium y-90 ibritumomab tiuxetan, therapeutic, per treatment dose, up to 40 millicuries
Added on: Sunday, January 01, 2006
Status changed on: Sunday, January 01, 2006
BETOS Classification : Standard imaging - nuclear medicine
Medicare coverage status:Carrier judgment